These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 34230221

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z, Wang Q, Deng MH, Han QL.
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C, Chen B, Wu B, Guo J, Cao Y.
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1.
    Gu J, Dai B, Shi X, He Z, Xu Y, Meng X, Zhu J.
    Aging (Albany NY); 2021 Sep 13; 13(17):21743-21757. PubMed ID: 34518440
    [Abstract] [Full Text] [Related]

  • 33. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway.
    Wu W, Li Q, Zhu Z, Li C, Lu P, Zhou X, Huang Y, Liu Y, Wang M, Gong J.
    Int J Biol Sci; 2022 Sep 13; 18(9):3777-3794. PubMed ID: 35813473
    [Abstract] [Full Text] [Related]

  • 34. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D, Xing N, Yang T, Liu J, Zhao H, He J, Ai Y, Yang J.
    Cancer Med; 2020 Oct 13; 9(19):7218-7230. PubMed ID: 32767662
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
    Zhang XM, Wang J, Liu ZL, Liu H, Cheng YF, Wang T.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32426838
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

  • 39. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, Fan SH, Zhang ZF, Shan Q, Li MQ, Hu B, Lu J, Chen GQ, Zheng YL.
    Cell Death Dis; 2018 Sep 20; 9(10):947. PubMed ID: 30237435
    [Abstract] [Full Text] [Related]

  • 40. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p.
    Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ.
    World J Gastroenterol; 2022 Sep 21; 28(35):5141-5153. PubMed ID: 36188725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.